ASP News

2019

• Fall/Winter 2019
  • Dosing Protocols updated including new guidance for Ceftolozane/tazobactam, Colistin, and Polymyxin B
  • OPAT page updated with indications and guidance for MAT
  • Microbiology nudge implemented
• Summer 2019
  • Sepsis antibiotic recommendations updated
  • C. difficile – Healthcare Professional’s Role in Preventing C.diff, Nursing Guidance on Testing (Stool Assessment Tool) and Support Staff’s Role in Preventing C.diff
  • Antibiograms distributed – Gram negative Combination therapy, 2018 Inpatient (color), Tri-fold Pocket Card, and Bellevue Overall
  • New team members joined
  • OPAT program started
  • Biocontainment Resources added
• Spring 2019
  • Educational Opportunities added – PGY2 Pharmacy Residency, ID Medical Fellowship, Antimicrobial Stewardship Summit, UNMC ID blog and Twitter feed.
  • C. difficile - Testing algorithm and Antibiotic Risk/Cost
  • Dalbavancin added to formulary

2018

• Fall 2018
  • Clostridium difficile infection testing algorithm
  • Oral Sulfa desensitization
  • Renal Dose Adjustments Updated
• Spring 2018
  • Alternatives to Using Piperacillin/Tazobactam with Vancomycin
  • Clostridium difficile Guidance modified
  • New Guidance on Skin and Soft Tissue Infections
  • Outpatient Antimicrobial Stewardship Primer
  • Renal Dose Adjustments Updated
  • Surgical Prophylaxis Guidance Updated
• Winter 2018
  • Penicillin Allergy Guidance Document
  • Peritoneal Dialysis Antimicrobial Dosing Recommendations

2017

• Fall 2017
  • Bezlotoxumab Added to Formulary
  • C. difficile Treatment Guidelines Updated
  • Diabetic Foot Infection Treatment Guideline Created
• Summer 2017
  • Rapid Blood Culture ID Panel Guidance Updated
  • Miltefosine Added to Formulary
  • Isavuconazole Added to Formulary
• February 2017
  • GI Pathogen Panel Restriction and Guidance Updated
  • Guideline on Antibiotic Use in Acute Exacerbations of COPD Published

2016

• November 2016
  • Renal Dose Adjustment Guidance for Antimicrobial CRRT Dosing Published
  • Guidance on Interpretation of Meningitis/Encephalitis Panel Published
  • Cefepime Dosing Protocol Updated
  • Antibiotic Prophylaxis for Open Fractures Updated
• New and Updated Guidelines, March 2016
  • Surgical prophylaxis recommendations updated for ENT and Cardiac procedures
  • Intra-operative Redosing Reminders Introduced
  • Renal dosing protocol updated
  • Adult Pneumococcal Vaccine Recommendations published

2015

• November 2015
  • Dose Rounding Policy for Antimicrobials Implemented
  • Changes to oral ribavirin treatment guidance including lung transplants
  • Guidelines for antibiotic use in open fractures published
  • New cephalosporin agents reviewed and ceftolozane/tazobactam added to the formulary
• Pneumonia Guidelines, July 2015
  • Community-Acquired Pneumonia
  • Pneumonia: Healthcare-associated, hospital-acquired, and ventilator-associated
• March 2015
  • Peramivir added to the formulary, March 2015
    • Peramivir
  • Changes to Urine and Blood Culture Orders (restricted)

2014

• New Guidelines Published, December 2014
  • Stool Pathogen Panel Introduced
  • New Institutional Antimicrobial Surgical Prophylaxis Guideline Published
  • Antimicrobial Stewardship Guidance now available as app
• Microbiology laboratory changes, July 2014
  • Changes in gram-negative pathogen susceptibility reporting
  • Rapid Blood Culture ID Panel Common Misinterpretations
  • TNMC urinary antibiogram developed
• New Clinical Guidelines Published, August 2014
  • Institutional Guidelines for the Treatment of Staphylococcus aureus Bloodstream Infection
  • Institutional Guidelines for the Evaluation and Treatment of Urinary Tract Infections and Asymptomatic Bacteriuria
• Formulary changes, June 2014
  • Oral Ribavirin for RSV added to formulary
  • Oral 3rd-generation cephalosporin cefdinir added to formulary
  • New formulations of Posaconazole available
• Levofloxacin Added to Formulary, February 2014
  • Therapeutic Interchange and Dosing Recommendations
• Multiple institutional treatment guidelines updated, February 2014
  • Community-acquired pneumonia
  • Healthcare-associated, Hospital-acquired, and Ventilator-associated Pneumonia
  • Antibiotic recommendations for severe sepsis and septic shock
  • Institutional guidelines for treatment of skin and soft tissue infections

2013

• November:
  • Rapid Blood Culture Pathogen Identification System Introduced and Antimicrobial Stewardship Recommendations for Interpretation
  • C. difficile Treatment Pathway Updated
• Continuous Venovenous Hemofiltration Anti-infective Dosing Added to Renal Dosing Document, April, 2013

2012

• Top 10 Tips from Antimicrobial Stewardship and Infection Control, December 2012
• Creating a Robust Antimicrobial Stewardship Program, July 2012
• Combination Gram-negative Antibiogram Developed, July 2012
• Fungal Antibiogram Developed, July 2012
• Aminoglycoside Dosing Protocol for Patients with Cystic Fibrosis, July 2012
• Added/expanded anti-infective restrictions for colistin, cytomegalovirus immune globulin and tigecycline, March 2012
• Comprehensive update to antimicrobial renal dosing document, March 2012
• Addition of Procalcitoinin and Publication of Institutional Guidance, February 2012

2011

• New Dosing Protocol for Cefepime and Piperacillin/tazobactam Implemented, November 2011
  • Piperacillin/tazobactam Dosing Protocol
  • Cefepime Dosing Protocol
• Fosfomycin Added to Inpatient Formulary, April 2011
• Multiple Institutional Guidelines Updated, April 2011
  • Institutional Guidelines for the Treatment of Invasive Candidiasis
  • Community-Acquired Pneumonia
  • Sepsis Empiric Antibiotic Recommendations
  • Guidelines for Treatment of Skin and Soft Tissue Infections
• Guidelines for the Prevention of Perinatal Group B Streptococcal Disease, April 2011

2010

• Pneumococcal and Legionella Urinary Antigen Tests Available at TNMC
• FDA Reports Increased Mortality with Tigecycline, September 2010
• Addition of a Reflex Test for Clostridium difficile, September 2010
  • Click here for updated pathway.
• Antimicrobial and Clinical Microbiology Guidebook updated and republished, July 2010
• Information regarding redundant anaerobic coverage ? now available, July 2010
• Institutional Guidelines for the Treatment of Invasive Candidiasis Implemented, February 2010
• Meropenem Dosing and Therapeutic Interchange Policy Implemented, February 2010
• Clostridium difficile Infection Pathway Updated, February 2010
• Meropenem and Ertapenem Added to the Formulary, Imipenem Removed, January 2010

2009

• Information for Interpretation of Viral Diagnostic Tests ? Now Available, October 2009
• Institutional Guidance for the 2009-2010 Influenza Season available, updated September 2009
• Ethanol Lock Technique Approved and Implemented, September 2009
• Updated Rabies Vaccination Schedule, August 2009
• New Clostridium difficile assay implemented, July 2009
• Pneumonia Pathways and Order Form updated, June 2009
• Influenza Treatment and Prophylaxis Guidelines for The Nebraska Medical Center, March 2009
• Pharmacokinetic Training Packet Updated, January 2009

2008

• TheraDoc Implemented for Antimicrobial Stewardship Program, October 2008
• Antibiotic Desensitization Protocols Implemented, May 2008

2007

• New procedures for management of C. difficile-associated disease implemented, July 2007
• Guidelines for treatment of skin and soft tissue infections implemented, June 2007
• FDA Warning - Linezolid (Zyvox), March 2007
• Micafungin replaces caspofungin on Inpatient Formulary, February 2007
• Benefits of Antimicrobial Surgical Prophylaxis Order Form, February 2007
• Zostavax added to Outpatient Formulary, January 2007

2006

• Renal Dosage Adjustment Guidelines for Antimicrobials Implemented, June 2006
  Additional information here
• Pneumonia Pathways and Order Form Implemented, May 2006
• Tigecycline added to Inpatient Formulary, March 2006

2005

• Therapeutic Interchange for Penicillins and Cephalosporins Implemented (Restricted), November 2005